Patient
P2B-099
completed Phase IIA Multicenter, Randomized, Open-Label Phase 2b Study to Investigate the Preliminary Efficacy and Safety of INNO-206 (Doxorubicin-EMCH) Compared to Doxorubicin in Subjects With Metastatic, Locally Advanced, or Unresectable Soft Tissue Sarcoma · Christian Medical College (Vellore, India) (Dr. Dubois)
consented 2013-04-09
Adverse events
1
Serious AEs
0
Open data queries
0
Luna dropout signal
—
not on Luna
Adverse events 1
moderate
assessed
2013-05-03
Grade 2 nausea with onset in cycle 1 (2013-05-03); assessed as not related to study drug (not related); resolved 2013-05-10; action: drug withdrawn.
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
This participant doesn't use Luna
Invite them from the site to track mood, adherence and check-ins.